Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 42405766

Prevalence, species diversity, and antimicrobial resistance profiles of Campylobacter spp. among children under five years of age with acute diarrhea in Ouagadougou, Burkina Faso.

Alimatou Héma·Issa Tondé·Jean Zongo·Marguerite Edith Malatala Nikiema·Evariste Bako·Ange Badjo·Mamadou Tamboura·Absatou Ky-Ba·Moussa Sangaré·Abdoul-Salam Ouédraogo·Mahamoudou Sanou
View original source ↗Export metadata ↓

Abstract

Campylobacter species are major causes of pediatric gastroenteritis worldwide, yet their burden remains underestimated in West Africa due to diagnostic challenges. This study aimed to determine the prevalence, species diversity, and antimicrobial resistance (AMR) profiles of Campylobacter spp. among children under 5 years of age with acute diarrhea in Ouagadougou, Burkina Faso. From 1 May 2023 to 30 April 2024, 383 stool samples were collected at the Centre Hospitalier Universitaire P&#xe9;diatrique Charles de Gaulle. Samples were analyzed using standard culture on Karmali selective agar and biochemical identification via the API Campy system. AMR testing was performed using the disk diffusion method. Campylobacter spp. were detected in 33 samples (8.6% prevalence). Infection was significantly associated with the 12-23 months age group (48.5%; P < 0.05). Campylobacter jejuni was the most common species (42.4%), followed by C. coli (21.2%) and C. fetus subsp. fetus (21.2%). Other species included C. hyointestinalis (6.1%), C. sputorum (6.1%), and C. lari (3.0%). Alarmingly, 100% of isolates were resistant to ampicillin, erythromycin, and tetracycline. High resistance rates were also observed for amoxicillin-clavulanic acid (93.9%) and ciprofloxacin (75.8%). Gentamicin showed the highest susceptibility (57.6%). All isolates (100%) were classified as multidrug-resistant (MDR). These results highlight a high prevalence of MDR Campylobacter in Ouagadougou, with total resistance to erythromycin, the first-line treatment. The identification of C. fetus at 42&#xb0;C suggests a high environmental and zoonotic pressure. These findings underscore the urgent need for enhanced genomic surveillance and updated clinical management guidelines for pediatric diarrhea in the region.IMPORTANCEThis study highlights the burden and antimicrobial resistance of Campylobacter spp. among children under five with acute diarrhea in Burkina Faso. Culture-based detection identified Campylobacter in 8.6% of children, confirming its role as an important but under-recognized cause of pediatric diarrheal disease. High levels of antimicrobial resistance, including complete resistance to erythromycin, raise concerns about the effectiveness of commonly used treatment options. The identification of multiple Campylobacter species, including C. fetus, suggests a broader diversity of circulating strains and possible zoonotic transmission pathways. These findings provide valuable baseline data to strengthen antimicrobial resistance surveillance, improve diagnostic practices, and support evidence-based treatment strategies in West African settings.

Explore related subjects

HumansBurkina FasoDiarrheaCampylobacter InfectionsAnti-Bacterial AgentsCampylobacterPrevalenceChild, PreschoolInfantFemaleFecesMicrobial Sensitivity TestsDrug Resistance, BacterialMaleOne Healthantimicrobial resistancechildrendiarrheamultidrug resistanceJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Alimatou H&#xe9;ma, Issa Tond&#xe9;, Jean Zongo, Marguerite Edith Malatala Nikiema, Evariste Bako, Ange Badjo, Mamadou Tamboura, Absatou Ky-Ba, Moussa Sangar&#xe9;, Abdoul-Salam Ou&#xe9;draogo, Mahamoudou Sanou. 2026-07-06. Prevalence, species diversity, and antimicrobial resistance profiles of Campylobacter spp. among children under five years of age with acute diarrhea in Ouagadougou, Burkina Faso.. https://doi.org/10.1128/spectrum.01243-26

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗